Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Apr 7;88(7):1012-6.
doi: 10.1038/sj.bjc.6600824.

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

M A Stokman  1 , F K L Spijkervet, F R Burlage, P U Dijkstra, W L Manson, E G E de Vries, J L N Roodenburg
Affiliations
Clinical Trial

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

M A Stokman et al. Br J Cancer. .

Abstract

Mucositis is an acute inflammation of the oral mucosa because of radiotherapy and/or chemotherapy. All patients receiving radiotherapy in the head and neck region develop oral mucositis. The aim of this study was to analyse the effects of selective oral flora elimination on radiotherapy-induced oral mucositis, in a double-blind, randomised, placebo-controlled trial. Sixty-five patients with a malignant tumour in the head and neck regions to be treated with primary curative or postoperative radiotherapy participated in this study. The patients received either the active lozenges of 1 g containing polymyxin E 2 mg, tobramycin 1.8 mg and amphotericin B 10 mg (PTA) (33 patients) or the placebo lozenges (32 patients), four times daily during the full course of radiotherapy. Mucositis, changes in the oral flora, quality of feeding and changes of total body weight were assessed. Mucositis score did not differ between the groups during the first 5 weeks of radiotherapy. Nasogastric tube feeding was needed in six patients (19%) of the placebo group and two patients (6%) of the PTA group (P=0.08). Mean weight loss after 5 weeks of radiation was less in the PTA group (1.3 kg) (s.d.: 3.0) than in the placebo group (2.8 kg) (s.d.: 2.9) (P=0.05). Colonisation index of Candida species and Gram-negative bacilli was reduced in the PTA group and not in the placebo group (P<0.05). No effect on other microorganisms was detected. In conclusion, selective oral flora elimination in head and neck irradiation patients does not prevent the development of severe mucositis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The mean mucositis score (±s.d.) for the PTA group (▵) and the placebo group (□).
Figure 2
Figure 2
Percentage of patients colonised for Candida species for the PTA group (lines) and the placebo group (solid).
Figure 3
Figure 3
Percentage of patients colonised for aerobic Gram-negative bacilli for the PTA group (lines) and the placebo group (solid).
See this image and copyright information in PMC

References

    1. Anonymous (1979) Handbook for Reporting Results of Cancer Treatment, Vol. 48. 15–22. WHO Offset Publication.
    1. Anonymous (1993) ICRU Report 50: Prescribing, Recording and Reporting Photon Beam Therapy. Bethesda, MD: ICRU Publications
    1. Baker DG. (1982) The radiobiological basis for tissue reactions in the oral cavity following therapeutic X-irradiation. A review. Arch Otolaryngol 108: 21–24 - PubMed
    1. Bernhoft CH, Skaug N (1985) Oral findings in irradiated edentulous patients. Int J Oral Surg 14: 416–427 - PubMed
    1. Jansma J, Vissink A, Spijkervet FKL, Roodenburg JLN, Panders AK, Vermey A, Szabo BG, Gravenmade EJ (1992) Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 70: 2171–2180 - PubMed

Publication types

Substances